Inactive Instrument

Press Releases Alteogen Inc Korea S.E.

Equities

End-of-day quote Korea S.E. Other stock markets
-	-

2023	Alteogen Inc. Announces Clinical Trial of Tergase Showed Zero Incidence of ADA	CI
2023	ALTEOGEN Inc. Reports Earnings Results for the First Quarter Ended March 31, 2023	CI

Alteogen And Sandoz Enter A Biosimilars Agreement Relating To Subcutaneous Products	23-03-03	AQ
Alteogen enters into an Exclusive License Agreement to Develop and Commercialize Biosimilar Products Enabled by Alteogen's Hybrozyme Technology	23-01-03	AQ

No results for this search